{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:28:05Z","timestamp":1786512485426,"version":"build-2736575974"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Ophthalmol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      To evaluate the physicochemical properties, contact lens compatibility,\n                      <jats:italic>in vitro<\/jats:italic>\n                      cytocompatibility, and repeated-dose ocular safety of a recombinant type III collagen-based contact lens rewetting drop formulation (Col RD).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Physicochemical properties were characterized using rheological testing and contact angle measurements. Total residual protein on rigid gas-permeable contact lenses was evaluated using an artificial tear fluid model, followed by non-enzymatic and enzymatic cleaning procedures.\n                      <jats:italic>In vitro<\/jats:italic>\n                      cytocompatibility was assessed using human corneal epithelial cells, including cell viability, adhesion, and migration assays. A one-month repeated-dose ocular safety study was conducted in New Zealand rabbits. Outcomes included slit-lamp examination, fluorescein staining, hematological and serum immunological analysis, and histopathological evaluation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Col RD exhibited shear-thinning rheological behavior and a hydrophilic sequence profile, with viscosity close to that of human tears under blinking-associated shear conditions. Contact angle analysis showed no significant differences compared with commercial lubricants. In the\n                      <jats:italic>in vitro<\/jats:italic>\n                      rigid gas-permeable lens model, Col RD did not increase total residual protein after enzymatic cleaning and showed significantly lower post-cleaning residual protein than the hyaluronic acid-based comparator under the tested conditions.\n                      <jats:italic>In vitro<\/jats:italic>\n                      , Col RD showed no significant adverse effects on corneal epithelial cell viability, adhesion, or migration compared with controls.\n                      <jats:italic>In vivo<\/jats:italic>\n                      , no evident ocular irritation, epithelial damage, inflammatory response, or structural abnormality was observed during the 30-day administration period. Hematological and serum immunological parameters showed no significant differences among groups. Histological analysis revealed no necrosis, fibrosis, neovascularization, or abnormal collagen deposition. Sirius Red showed no evident alteration in type I\/III collagen distribution.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Recombinant collagen-based contact lens rewetting drops showed favorable rheological properties, acceptable\n                      <jats:italic>in vitro<\/jats:italic>\n                      cytocompatibility, and no evident ocular irritation after repeated topical administration in rabbits. In an\n                      <jats:italic>in vitro<\/jats:italic>\n                      rigid gas-permeable lens model, Col RD showed low total residual protein after enzymatic cleaning compared with the hyaluronic acid-based formulation. These findings support the preliminary safety and feasibility of incorporating recombinant type III collagen into a PVA-containing lubricating formulation for contact lens rewetting drops. Further studies are needed to evaluate clinical rewetting performance, broader lens-material compatibility, long-term formulation stability, and the relative contribution of recombinant collagen and PVA.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fopht.2026.1861277","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:42:01Z","timestamp":1786509721000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Preclinical evaluation of recombinant type III collagen-based contact lens rewetting drops"],"prefix":"10.3389","volume":"6","author":[{"given":"Siyang","family":"Liu","sequence":"first","affiliation":[{"name":"Jiangsu Trautec Medical Technology Co.","place":["Ltd, Changzhou, China"]},{"name":"Anhui Trautec Medical Technology Co.","place":["Ltd, Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yefei","family":"Shi","sequence":"additional","affiliation":[{"name":"Anhui Trautec Medical Technology Co.","place":["Ltd, Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxin","family":"Zhai","sequence":"additional","affiliation":[{"name":"Jiangsu Trautec Medical Technology Co.","place":["Ltd, Changzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[{"name":"Jiangsu Trautec Medical Technology Co.","place":["Ltd, Changzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzhuang","family":"Teng","sequence":"additional","affiliation":[{"name":"Jiangsu Trautec Medical Technology Co.","place":["Ltd, Changzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[{"name":"Jiangsu Trautec Medical Technology Co.","place":["Ltd, Changzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Meng","sequence":"additional","affiliation":[{"name":"Jiangsu Trautec Medical Technology Co.","place":["Ltd, Changzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Jiangsu Trautec Medical Technology Co.","place":["Ltd, Changzhou, China"]},{"name":"Anhui Trautec Medical Technology Co.","place":["Ltd, Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohui","family":"Pan","sequence":"additional","affiliation":[{"name":"Eye Research Center, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Eye Hospital, Wenzhou Medical University","place":["Hangzhou, China"]},{"name":"State Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University","place":["Wenzhou, China"]},{"name":"Zhejiang Key Laboratory of Key Technologies for Visual Pathway Reconstruction, Eye Hospital, Wenzhou Medical University","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihang","family":"Li","sequence":"additional","affiliation":[{"name":"Jiangsu Trautec Medical Technology Co.","place":["Ltd, Changzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxian","family":"Hu","sequence":"additional","affiliation":[{"name":"Jiangsu Trautec Medical Technology Co.","place":["Ltd, Changzhou, China"]},{"name":"State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/opx.0000000000002255","article-title":"Eleven years of orthokeratology contact lens wear for slowing myopia progression in children","volume":"102","author":"Santodomingo-Rubido","year":"2025","journal-title":"Optom Vis Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/11206721231219532","article-title":"Myopia management algorithm. Annexe to the article titled update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute","volume":"34","author":"Tapaszt\u00f3","year":"2024","journal-title":"Eur J Ophthalmol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2147\/opto.S405204","article-title":"How can we better inform patients of the importance of contact lens compliance?: Current perspectives","volume":"16","author":"Fogt","year":"2024","journal-title":"Clin Optom (Auckl)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2023.101852","article-title":"Long-term effects of tear film component deposition on the surface and optical properties of two different orthokeratology lenses","volume":"46","author":"Su","year":"2023","journal-title":"Cont Lens Anterior Eye"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015751.pub2","article-title":"Lubricating drops for contact lens discomfort in adults","volume":"9","author":"Caffery","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2020.04.013","article-title":"A review of the compatibility of topical artificial tears and rewetting drops with contact lenses","volume":"43","author":"Pucker","year":"2020","journal-title":"Cont Lens Anterior Eye"},{"key":"B7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/opto.S350185","article-title":"Artificial tears: A systematic review","volume":"15","author":"Semp","year":"2023","journal-title":"Clin Optom (Auckl)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2147\/opth.S428725","article-title":"Safe and effective management of dry eye symptoms with hydroxypropyl guar and hyaluronic acid dual-polymer lubricating eye drops: A review of preclinical and clinical studies","volume":"17","author":"Srinivasan","year":"2023","journal-title":"Clin Ophthalmol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41563-025-02241-7","article-title":"Instant assembly of collagen for tissue engineering and bioprinting","volume":"24","author":"Gong","year":"2025","journal-title":"Nat Mater"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2024.114146","article-title":"Novel collagen gradient membranes with multiphasic structures: Preparation, characterization, and biocompatibility","volume":"243","author":"Huang","year":"2024","journal-title":"Colloids Surf B Biointerfaces"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/s41598-017-01476-y","article-title":"In vitro fibrillogenesis of tropocollagen type III in collagen type I affects its relative fibrillar topology and mechanics","volume":"7","author":"Asgari","year":"2017","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2019.05.003","article-title":"Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases","volume":"707","author":"Kuivaniemi","year":"2019","journal-title":"Gene"},{"key":"B13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jtos.2020.10.006","article-title":"Corneal stromal wound healing: Major regulators and therapeutic targets","volume":"19","author":"Kamil","year":"2021","journal-title":"Ocul Surf"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/polym13172973","article-title":"High-resolution bioprinting of recombinant human collagen type III","volume":"13","author":"Gibney","year":"2021","journal-title":"Polymers (Basel)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2015.07.009","article-title":"The structural and optical properties of type III human collagen biosynthetic corneal substitutes","volume":"25","author":"Hayes","year":"2015","journal-title":"Acta Biomater"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-1348","article-title":"Tissue-engineered recombinant human collagen-based corneal substitutes for implantation: Performance of type I versus type III collagen","volume":"49","author":"Merrett","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2007.11.011","article-title":"Recombinant human collagen for tissue engineered corneal substitutes","volume":"29","author":"Liu","year":"2008","journal-title":"Biomaterials"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(82)90515-0","article-title":"A simple method for displaying the hydropathic character of a protein","volume":"157","author":"Kyte","year":"1982","journal-title":"J Mol Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2023.102104","article-title":"Impact of in vitro lens deposition and removal on bacterial adhesion to orthokeratology contact lenses","volume":"47","author":"Yamasaki","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1385\/1-59259-584-7:531","article-title":"Protein identification and analysis tools in the ExPASy server","volume":"112","author":"Wilkins","year":"1999","journal-title":"Methods Mol Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"075107","DOI":"10.1063\/5.0207182","article-title":"Exploring tear viscosity with quartz crystal microbalance technology","volume":"95","author":"Mu\u00f1oz","year":"2024","journal-title":"Rev Sci Instrum"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1996.0121","article-title":"Analysis of human tear fluid components, inhibiting protein adhesion to plastic surfaces","volume":"63","author":"Kuizenga","year":"1996","journal-title":"Exp Eye Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s0142-9612(02)00542-2","article-title":"Multiple surface properties of worn RGP lenses and adhesion of Pseudomonas aeruginosa","volume":"24","author":"Bruinsma","year":"2003","journal-title":"Biomaterials"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2020.01.006","article-title":"A recombinant human collagen hydrogel for the treatment of partial-thickness burns: A prospective, self-controlled clinical study","volume":"47","author":"Ben","year":"2021","journal-title":"Burns"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/sap.0000000000004418","article-title":"Encapsulation of adipose-derived stem cells in collagen-based hydrogel: Regenerative therapy for burn wound healing","volume":"95","author":"Sitoresmi","year":"2025","journal-title":"Ann Plast Surg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1675212","article-title":"Modified recombinant collagen-peptide\/gallic acid grafted chitosan composites with antibacterial and antioxidant property for wound dressing: a preliminary study","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/jat.4741","article-title":"Food safety evaluation of recombinant humanized type III collagen produced by Komagataella phaffii SMD1168-2COL3","volume":"45","author":"Dai","year":"2025","journal-title":"J Appl Toxicol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/s0142-9612(01)00163-6","article-title":"The relationship between contact lens surface charge and in-vitro protein deposition levels","volume":"22","author":"Soltys-Robitaille","year":"2001","journal-title":"Biomaterials"},{"key":"B29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/08927014.2021.2019225","article-title":"Development of an enzymatic method for the evaluation of protein deposition on contact lenses","volume":"38","author":"Masoudi","year":"2022","journal-title":"Biofouling"},{"key":"B30","article-title":"The interaction of insoluble collagen and sulphated polysaccharides","volume":"104","author":"Serafini-Fracassini","year":"1967","journal-title":"Biochem J"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.131034","article-title":"Collagen\/gelatin and polysaccharide complexes enhance gastric retention and mucoadhesive properties","volume":"266","author":"Ahmad","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102452","article-title":"Recombinant collagen in regenerative medicine: Expression strategies, structural design, and translational applications","volume":"35","author":"He","year":"2025","journal-title":"Mater Today Bio"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1049\/enb.2017.0003","article-title":"Production of recombinant collagen: state of the art and challenges","volume":"1","author":"Wang","year":"2017"}],"container-title":["Frontiers in Ophthalmology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2026.1861277\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:42:06Z","timestamp":1786509726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2026.1861277\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":33,"alternative-id":["10.3389\/fopht.2026.1861277"],"URL":"https:\/\/doi.org\/10.3389\/fopht.2026.1861277","relation":{},"ISSN":["2674-0826"],"issn-type":[{"value":"2674-0826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"article-number":"1861277"}}